Missouri Board of Public Building Missouri; Appropriations; General Obligation Jul 12

  • ID: 2204094
  • July 2012
  • Region: Missouri
  • Standard & Poors
1 of 3


  • Missouri
  • Missouri Brd of Pub Bldg
  • MORE

Standard & Poor's Ratings Services assigned its 'AA+' rating and stable outlook to the Missouri Board of Public Buildings 2012A special obligation bonds, reflecting the appropriation pledge of the state of Missouri. At the same time, we affirmed our 'AAA' rating on the state's general obligation (GO) bonds and 'AA+' rating on the state's appropriation debt outstanding. The ratings reflect Standard & Poor's assessment of the state's: Strong and diverse economic base; Good financial management; Strong reserves in the form of a budget reserve fund that can only be accessed under limited circumstances; and Moderate debt burden. The certificates of participation and leasehold revenue bonds are subject to annual appropriation and the GO bonds are secured by the state's full...

Companies mentioned in this report are:
- Missouri
- Missouri Brd of Pub Bldg

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

- Missouri
- Missouri Brd of Pub Bldg

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.